Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

Johnson & Johnson Reports Q2 2022 Results

Business Wire July 19, 2022

Johnson & Johnson's Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022

Business Wire July 18, 2022

Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research

PR Newswire June 20, 2022

Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments

PR Newswire June 8, 2022

Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

PR Newswire May 12, 2022

Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company

PR Newswire May 11, 2022

Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference

PR Newswire May 2, 2022

Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)

PR Newswire April 25, 2022

Johnson & Johnson to Participate in the UBS Global Healthcare Conference

PR Newswire April 20, 2022

Johnson & Johnson Reports Q1 2022 Results

PR Newswire April 19, 2022

Johnson & Johnson Announces Dividend Increase of 6.6%

PR Newswire April 19, 2022

Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference

PR Newswire April 7, 2022

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

PR Newswire March 15, 2022

Talc-Cancer Lawsuits Play Critical Role in Exposing Johnson & Johnson's Unethical Experiments on Prisoners

PR Newswire March 9, 2022

Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease

PR Newswire March 1, 2022

Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors

PR Newswire February 15, 2022

Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference

PR Newswire February 9, 2022

Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference

PR Newswire February 7, 2022

Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference

PR Newswire January 27, 2022

Johnson & Johnson Reports Q4 and Full-Year 2021 Results

PR Newswire January 25, 2022